Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 335(1): 162-7, 2005 Sep 16.
Article in English | MEDLINE | ID: mdl-16055081

ABSTRACT

Calcineurin (CN) is thought to play an important role in the immune system by regulating cytokine production, for example, interleukin-2 (IL-2) in T-lymphocytes. We have previously shown that physiological concentrations of Zn2+ inhibit CN activity in vitro [K. Takahashi, E. Akaishi, Y. Abe, R. Ishikawa, S. Tanaka, K. Hosaka, Y. Kubohara, Zinc inhibits calcineurin activity in vitro by competing with nickel, Biochem. Biophys. Res. Commun. 307 (2003) 64-68], in spite of the fact that Zn2+ is an essential element of the CN catalytic domain. In this study, in order to assess whether Zn2+ regulates (suppresses) CN activity in vivo and whether Zn2+ can be used as an anti-inflammatory and/or immunosuppressive drug, we examined the effects of Zn2+ on IL-2 production induced by the mitogen, concanavalin A (ConA), in Jurkat T-cells. Zn2+ at 0.2 mM suppressed ConA-induced IL-2 accumulation in the medium of an in vitro culture of Jurkat cells. Zn2+ at 0.03-0.3 mM dose-dependently suppressed ConA-induced IL-2 mRNA expression in Jurkat cells. Zn2+ also suppressed IL-2 mRNA expression induced by phorbol ester (PMA) and ionomycin. Furthermore, Zn2+ and the immunosuppressant FK506 showed an additive inhibitory effect on ConA-induced IL-2 mRNA expression. These results suggest that exogenously added Zn2+ may disturb (increase) the intracellular Zn2+ concentration and inhibit CN activity, thereby suppressing IL-2 production in Jurkat cells. The present study further indicates that Zn2+ may have therapeutic potential in the treatment of T-cell related inflammation and also that Zn2+ may be utilized as a supplemental drug with FK506.


Subject(s)
Concanavalin A/pharmacology , Interleukin-2/biosynthesis , Mitogens/pharmacology , Zinc/pharmacology , Cations, Divalent/chemistry , Cations, Divalent/pharmacology , Cell Survival/drug effects , Gene Expression Regulation, Neoplastic , Humans , Interleukin-2/genetics , Ionomycin/pharmacology , Jurkat Cells , Phorbol 12,13-Dibutyrate/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Tacrolimus/pharmacology , Zinc/chemistry
2.
Eur J Pharmacol ; 485(1-3): 21-9, 2004 Feb 06.
Article in English | MEDLINE | ID: mdl-14757120

ABSTRACT

The differentiation-inducing factor-1 (DIF-1) is a signal molecule that induces stalk cell differentiation in the cellular slime mold Dictyostelium discoideum. In addition, DIF-1 is a potent antileukemic agent that induces growth arrest in K562 cells. In this study, we investigated the mechanism of action of DIF-1 in K562 cells in the light of cell-cycle regulators such as cyclins, retinoblastoma protein (pRb), and the mitogen-activated protein kinase (MAPK) family. DIF-1 down-regulated cyclins D/E and a phosphorylated form of pRb (p-pRb), and thereby induced G(1) arrest of the cell cycle. DIF-1 inactivated the extracellular signal-regulated kinase (ERK) in a biphasic manner but did not affect the c-Jun N-terminal kinase (JNK) or p38 MAPK. The MEK (MAPK kinase) inhibitor, U0126, which has been shown to induce growth arrest, inactivated ERK and down-regulated cyclins D and E. Although DIF-1 activated the phosphatidylinositol 3-kinase (PI-3K)/Akt pathway, neither wortmannin nor 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002; PI-3K inhibitors) cancelled DIF-1-induced growth arrest. The present results suggest that ERK inactivation may be involved in DIF-1-induced growth arrest and that PI-3K activity is not required for DIF-1-induced growth arrest in K562 cells.


Subject(s)
Antineoplastic Agents/pharmacology , Caenorhabditis elegans Proteins/pharmacology , Carrier Proteins/pharmacology , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Proteins , Antineoplastic Agents/chemistry , Caenorhabditis elegans Proteins/chemistry , Carrier Proteins/chemistry , Cell Division/drug effects , Cell Division/physiology , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Hexanones , Humans , Hydrocarbons, Chlorinated , K562 Cells , Leukemia/pathology , Leukemia/prevention & control , Mitogen-Activated Protein Kinase 3
3.
Biochem Biophys Res Commun ; 307(1): 64-8, 2003 Jul 18.
Article in English | MEDLINE | ID: mdl-12849981

ABSTRACT

Calcineurin (CN) is a Ca(2+)/calmodulin (CaM)-dependent protein serine/threonine phosphatase that contains Zn(2+) in its catalytic domain and can be stimulated by divalent ions such as Mn(2+) and Ni(2+). In this study, the role of exogenous Zn(2+) in the regulation of CN activity and its relevance to the role of Ni(2+) was investigated. Zn(2+) at a concentration range of 10nM-10 micro M inhibited Ni(2+)-stimulated CN-activity in vitro in a dose-dependent manner and approximately 50% inhibition was attained with 0.25 micro M Zn(2+). Kinetic analysis showed that Zn(2+) inhibited the activity of CN by competing with Ni(2+). Interaction of CN and CaM was not inhibited with Zn(2+) at 10 micro M. Zn(2+) never affected the activity of cAMP phosphodiesterase 1 or myosin light-chain kinase (CaM-dependent enzymes) and rather activated alkaline phosphatase. The present results indicate that Zn(2+) should be a potent inhibitor for CN activity although this ion is essential for CN.


Subject(s)
Calcineurin Inhibitors , Nickel/metabolism , Zinc/metabolism , Alkaline Phosphatase/metabolism , Animals , Calcineurin/metabolism , Calmodulin/metabolism , Catalytic Domain , Cattle , Dose-Response Relationship, Drug , Enzyme Activation , Myosin-Light-Chain Kinase/metabolism , Phosphodiesterase I , Phosphoric Diester Hydrolases/metabolism , Zinc/pharmacology
4.
Eur J Pharmacol ; 460(2-3): 93-8, 2003 Jan 24.
Article in English | MEDLINE | ID: mdl-12559368

ABSTRACT

Differentiation-inducing factor-1 (DIF-1; 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one) is a putative morphogen that induces stalk-cell formation in the cellular slime mold Dictyostelium discoideum. DIF-1 has previously been shown to suppress cell growth in mammalian cells. In this study, we examined the effects of DIF-1 on the progesterone-induced germinal vesicle breakdown in Xenopus laevis, which is thought to be mediated by a decrease in intracellular cAMP and the subsequent activation of mitogen-activated protein kinase (MAPK) and maturation-promoting factor, a complex of cdc2 and cyclin B, which regulates germinal vesicle breakdown. DIF-1 at 10-40 microM inhibited progesterone-induced germinal vesicle breakdown in de-folliculated oocytes in a dose-dependent manner. Progesterone-induced cdc2 activation, MAPK activation, and c-Mos accumulation were inhibited by DIF-1. Furthermore, DIF-1 was found to inhibit the progesterone-induced cAMP decrease in the oocytes. These results indicate that DIF-1 inhibits progesterone-induced germinal vesicle breakdown possibly by blocking the progesterone-induced decrease in [cAMP](i) and the subsequent events in Xenopus oocytes.


Subject(s)
Dictyostelium/chemistry , Hexanones/pharmacology , Oocytes/drug effects , Progesterone/pharmacology , Animals , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Female , Hexanones/chemistry , Maturation-Promoting Factor/metabolism , Mitogen-Activated Protein Kinases/metabolism , Oocytes/growth & development , Oocytes/metabolism , Proto-Oncogene Proteins c-mos/metabolism , Xenopus laevis
SELECTION OF CITATIONS
SEARCH DETAIL
...